Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial

Evaluation of preclinical evidence prior to initiating early-phase clinical studies has typically been performed by selecting individual studies in a non-systematic process that may introduce bias. Thus, in preparation for a first-in-human trial of mesenchymal stromal cells (MSCs) for septic shock,...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:eLife
Auteurs principaux: Lalu, Manoj M, Sullivan, Katrina J, Mei, Shirley HJ, Moher, David, Straus, Alexander, Fergusson, Dean A, Stewart, Duncan J, Jazi, Mazen, MacLeod, Malcolm, Winston, Brent, Marshall, John, Hutton, Brian, Walley, Keith R, McIntyre, Lauralyn
Format: Artigo
Langue:Inglês
Publié: eLife Sciences Publications, Ltd 2016
Sujets:
Epidemiology and Global Health
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5153252/
https://ncbi.nlm.nih.gov/pubmed/27870924
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7554/eLife.17850
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires